In line with these studies, the analysis of publicly available DNA microarray data of 876 gastric cancer patients by means of the Kaplan–Meier plotter software [80] demonstrated that high chemerin tumor expression reduced OS of gastric cancer patients (p = 0.0059; Figure 5) and also higher tissue expression of CMKLR1 and GPR1 significantly decreased OS of gastric cancer patients (p = 0.0085 or p = 1.7 × 10−7, respectively). The gene discussed is RARRES2; the disease is gastric cancer.